Home - Products - Endocrinology/Hormones - Androgen Receptor (AR) - Nandrolone phenpropionate

Nandrolone phenpropionate

CAS No. 62-90-8

Nandrolone phenpropionate( —— )

Catalog No. M22550 CAS No. 62-90-8

Nandrolone phenpropionate is an androgen receptor agonist. It mainly used to treat women with breast cancer and osteoporosis.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	48	In Stock
10MG	35	In Stock
25MG	53	In Stock
50MG	73	In Stock
100MG	107	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Nandrolone phenpropionate
Note

Research use only, not for human use.
Brief Description

Nandrolone phenpropionate is an androgen receptor agonist. It mainly used to treat women with breast cancer and osteoporosis.
Description

Nandrolone phenpropionate is an androgen receptor agonist. It mainly used to treat women with breast cancer and osteoporosis.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Endocrinology/Hormones
Target

Androgen Receptor (AR)
Recptor

androgen receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

62-90-8
Formula Weight

406.6
Molecular Formula

C27H34O3
Purity

>98% (HPLC)
Solubility

——
SMILES

CC12CCC3C(C1CCC2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CCC35
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Kahn S B , Conroy J F , Brodsky I . Effect of nandrolone phenpropionate on myelopoiesis[J]. Journal of Medicine, 1974, 5(6):303.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

LGD-2226

LGD-2226 (LGD2226) is an orally active, selective androgen receptor modulator (SARM) with binding Ki of 1 nM.
EPI-001

EPI-001 is a small molecule that blocks transactivation of the androgen Receptor (AR) NTD (IC50=6 uM).
Rezvilutamide

Rezvilutamide (SHR3680) is an orally available androgen receptor inhibitor that crosses the blood-brain barrier and has antitumor activity.Rezvilutamide (SHR3680) is used in the study of metastatic desmoplasia-resistant prostate cancer.

Sign In Join Free